Cargando…

Quantitative zeptomolar imaging of miRNA cancer markers with nanoparticle assemblies

Multiplexed detection of small noncoding RNAs responsible for posttranscriptional regulation of gene expression, known as miRNAs, is essential for understanding and controlling cell development. However, the lifetimes of miRNAs are short and their concentrations are low, which inhibits the developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Aihua, Sun, Maozhong, Xu, Liguang, Hao, Changlong, Wu, Xiaoling, Xu, Chuanlai, Kotov, Nicholas A., Kuang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397542/
https://www.ncbi.nlm.nih.gov/pubmed/30808736
http://dx.doi.org/10.1073/pnas.1810764116
Descripción
Sumario:Multiplexed detection of small noncoding RNAs responsible for posttranscriptional regulation of gene expression, known as miRNAs, is essential for understanding and controlling cell development. However, the lifetimes of miRNAs are short and their concentrations are low, which inhibits the development of miRNA-based methods, diagnostics, and treatment of many diseases. Here we show that DNA-bridged assemblies of gold nanorods with upconverting nanoparticles can simultaneously quantify two miRNA cancer markers, namely miR-21 and miR-200b. Energy upconversion in nanoparticles affords efficient excitation of fluorescent dyes via energy transfer in the superstructures with core–satellite geometry where gold nanorods are surrounded by upconverting nanoparticles. Spectral separation of the excitation beam and dye emission wavelengths enables drastic reduction of signal-to-noise ratio and the limit of detection to 3.2 zmol/ng(RNA) (0.11 amol or 6.5 × 10(4) copies) and 10.3 zmol/ng(RNA) (0.34 amol or 2.1 × 10(5) copies) for miR-21 and miR-200b, respectively. Zeptomolar sensitivity and analytical linearity with respect to miRNA concentration affords multiplexed detection and imaging of these markers, both in living cells and in vivo assays. These findings create a pathway for the creation of an miRNA toolbox for quantitative epigenetics and digital personalized medicine.